Uni-Bio Science Group Limited
UNBSF
$0.0036
$0.00360.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 14.47% | 8.62% | 3.01% | 6.40% | 10.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.47% | 8.62% | 3.01% | 6.40% | 10.11% |
| Cost of Revenue | 0.37% | -10.72% | -20.30% | -16.52% | -12.83% |
| Gross Profit | 17.77% | 13.51% | 9.32% | 13.07% | 17.33% |
| SG&A Expenses | 8.62% | 0.86% | -6.50% | 1.90% | 11.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 54.84% | 25.86% | -25.25% | -50.77% | -75.85% |
| Total Operating Expenses | 12.10% | 3.31% | -4.99% | -1.20% | 2.76% |
| Operating Income | 26.31% | 37.07% | 49.05% | 57.81% | 71.27% |
| Income Before Tax | 20.40% | 32.81% | 46.07% | 57.17% | 75.37% |
| Income Tax Expenses | 67.81% | 3.64% | -35.93% | -20.70% | 5.20% |
| Earnings from Continuing Operations | 17.04% | 35.67% | 56.60% | 67.03% | 84.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.04% | 35.67% | 56.60% | 67.03% | 84.07% |
| EBIT | 26.31% | 37.07% | 49.05% | 57.81% | 71.27% |
| EBITDA | 23.86% | 37.67% | 53.60% | 54.46% | 55.49% |
| EPS Basic | 28.57% | 46.15% | 66.67% | 88.89% | 133.33% |
| Normalized Basic EPS | 20.00% | 30.00% | 40.00% | 50.00% | 66.67% |
| EPS Diluted | 28.57% | 46.15% | 66.67% | 88.89% | 133.33% |
| Normalized Diluted EPS | 20.00% | 30.00% | 40.00% | 50.00% | 66.67% |
| Average Basic Shares Outstanding | -3.53% | -2.52% | -1.52% | -0.69% | 0.10% |
| Average Diluted Shares Outstanding | -3.53% | -2.52% | -1.52% | -0.69% | 0.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |